Replies to post #302 on Deltagen (DGEN)

[finbar99]

>>you might not be aware that back in the day the big pharma's all ponied up 25 million each

along with giving DGEN royalty rights on top of the 25 million for any drugs commercialized from the data, and the mice were extra. The major deal that mgmt pulled off to pull the company out of bk was a multi-million deal with the NIH and the Wellcome-Trust whereby mice and the database were made available to academic institutions on a royalty free basis - but royalty rights were retained for any commercial development of any academic development. Run Deltagen through the US Patent Office database - they hold dozens. Hundreds more were in the application process pipeline but had to be abandoned as the legal fees for patent perfection were not sustainable - another proper call by mgmt. All to say, this company has been an absolute steal at a nickel.